Podcasts about Allergy

Hardware is… easy now?! That's what Matt Truebe said when he pitched three devices and a plan to help families with food allergies and asthma. He has tons of experience, but between telehealth and hardware, is this business just too complicated for the VCs? This is The Pitch for Above Health. Featuring investors Cyan Banister, Charles Hudson, Immad Akhund, Monique Woodard, and Rohit Gupta. ... Watch Matt's pitch uncut on Patreon (@ThePitch) Subscribe to our email newsletter: insider.pitch.show Learn more about The Pitch Fund: thepitch.fund *Disclaimer: No offer to invest in Above Health is being made to or solicited from the listening audience on today's show. The information provided on this show is not intended to be investment advice and should not be relied upon as such. The investors on today's episode are providing their opinions based on their own assessment of the business presented. Those opinions should not be considered professional investment advice. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Earlier this month, more than 2,500 allergists and healthcare professionals gathered in Orlando, Florida, for the annual meeting of the American College of Allergy, Asthma & Immunology—better known as ACAAI. It's one of the biggest events of the year where experts share the latest research, treatments, and guidelines in allergy and immunology. We're thrilled to be joined by this year's keynote speaker, program chair—and FAACT Medical Board Member—Dr. Kristin Sokol, MD, MS, MPH, who shares highlights and key takeaways from this cutting-edge meeting.Resources to keep you in the know:American College of Allergy Asthma and Immunology (ACAAI)Schreiber Allergy: Kristin Sokol, M.D., MS, MPH, FACAAI, FAAAAIYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: GenentechThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

In this episode, we tackle the challenge of separating allergy fact from fiction in an age of rampant online misinformation. Dr. Zachary Rubin, a double board-certified pediatrician and allergist, shares insights on common allergy myths circulating on social media. We explore misconceptions about food allergies vs. intolerances, respiratory allergies, eczema management, anaphylaxis treatment, and allergy testing interpretation. Learn how to navigate patient conversations about gluten sensitivity, pet allergies, and "natural" allergy cures. This episode provides primary care clinicians with practical strategies to address patient concerns rooted in online misinformation and optimize allergy diagnosis and management in clinical practice.

Join Dr. Nicholas Cline and host Marcella Feathers as they discuss the reintroduction of the Penicillin Allergy Verification and Evaluation (PAVE) Act.  The PAVE Act would require physicians to verify a penicillin allergy during the "Welcome to Medicare" preventive visit and annual Medicare wellness visits.  Penicillin was discovered in 1928 by Alexander Fleming and is an inexpensive but very effective antibiotic. Dr. Cline shares why the majority of patients who believe they're allergic to penicillin may have an inaccurate diagnosis and what options are available for determining if an allergy actually exists. Whether or not you're a Medicare patient, confirming a penicillin allergy can save you money and time!

Send me a question or story!As dermatologists, we LOVE topical therapy. However there are some basic things that need to be considered when suggesting a protocol. What are you treating?What is the ultimate goal?What do you or the owner have?Can it happen?Check out some simple tips on this week's episode of The Derm Vet podcast!00:00 – Intro01:15 – Q1: Why Are You Using Topical Therapy?04:41 – Q2: What is the Goal of the Product?05:58 – Q3: What Do You Have Available?08:45 – Q4: Can the Owner Do It?11:34 – Overview12:44 – Outro

The tickborne illness alpha-gal syndrome affects what you can eat. For those who contract it, mealtime becomes a minefield. Plus: American agriculture depends on foreign workers, but President Donald Trump's immigration clampdown is shrinking a farm workforce that many say was already too small.

Avoidance has long been the standard for managing food allergies. But new options, such as oral immunotherapy (OIT) and biologic medications like Xolair (omalizumab), are changing the landscape. With more choices available, many patients and parents are wondering how to start the conversation with their allergist and what questions to ask. Kortney and Dr. Payel Gupta talk with Dr. Shahzad Mustafa, a board-certified allergist and immunologist, about how patients can navigate today's food allergy treatments with confidence. Together, they explore what to consider before starting OIT or Xolair, how to set realistic expectations, and why strict avoidance is still the right choice for many families. What we cover about food allergy treatment options: Food Allergy Avoidance: Why it remains an effective and valid approach for many, and how to make it work in daily life, including the nuances that make every case unique. Oral Immunotherapy (OIT): What it involves, who it's best suited for, and what families should know about time, cost, and safety. Xolair (omalizumab): How this injection therapy works to reduce reactions from accidental exposures and what it doesn't do. Setting expectations: How to talk with your allergist about your goals, quality of life, and what “success” really looks like. More episodes about food allergies Ep. 129: Omalizumab for Multiple Food Allergies – The OUtMATCH Trial Ep. 98: Food Allergy Treatment and Management More resources about food allergies Food Allergy Treatment & Management ___ Made in partnership with The Allergy & Asthma Network. Thanks to Genentech for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

FULL SHOW: Tuesday, November 11th, 2025 Curious if we look as bad as we sound? Follow us @BrookeandJeffrey: Youtube Instagram TikTok BrookeandJeffrey.comSee omnystudio.com/listener for privacy information.

Nothing ruins a nature walk like a tick bite, and scientists say concerns from those bites are growing beyond Lyme disease. Brad Kutner has this report on a new study out of Virginia Commonwealth University. 

Overview: In this episode, Dr Joel Gallant gives a history of antiretroviral therapy and HIV drug resistance, drawing on his personal and professional experience beginning in the early 1980s. The views expressed are those of the panelist and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2023 and the content reflects the information available at that time. Guest: Joel Gallant, MD, MPH    For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus    References AIDSVu.org. New HIV diagnoses. 2023. Available from: https://aidsvu.org/local-data/united-states/south/ (Accessed May 19, 2025) AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Alonso A, de Irala J. Strategies in HIV prevention: the A-B-C approach. Lancet 2004;364:1033. Available from: https://doi.org/10.1016/s0140-6736(04)17050-5 Bacheler L, Jeffrey S, Hanna G et al. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol 2001;75:4999–5008. Available from: https://doi.org/10.1128/jvi.75.11.4999-5008.2001 Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–71. Available from: https://doi.org/10.1126/science.6189183 Bayer R, Edington C. HIV testing, human rights, and global AIDS policy: exceptionalism and its discontents. J Health Polit Policy Law 2009;34:301–23. Available from: https://doi.org/10.1215/03616878-2009-002 Centers for Disease Control and Prevention. Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm Centers for Disease Control and Prevention. Preventing HIV. 2024. Available from: https://www.cdc.gov/hiv/prevention/index.html (Accessed May 22, 2025) Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. Available from: https://doi.org/10.1056/NEJMoa1105243 Cuevas JM, Geller R, Garijo R et al. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol 2015;13:e1002251. Available from: https://doi.org/10.1371/journal.pbio.1002251 Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/optimizing-antiretroviral-therapy (Accessed May 19, 2025) Dragovic G. Acute pancreatitis in HIV/AIDS patients: an issue of concern. Asian Pac J Trop Biomed 2013;3:422–425. Available from: https://doi.org/10.1016%2FS2221-1691(13)60091-X Eron JJ, Benoit SL, Jemsek J et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med 1995;333:1662–9. Available from: https://doi.org/10.1056/nejm199512213332502 Gandhi RT, Tashima KT, Smeaton LM et al. Long-term outcomes in a large randomized trial of HIV-1 salvage therapy: 96-week results of AIDS clinical trials group A5241 (OPTIONS). J Infect Dis 2020;221:1407–15. Available from: https://doi.org/10.1093/infdis/jiz281 Getting to Zero San Francisco. HIV epidemiology annual report 2017. 2022. Available from: https://gettingtozerosf.org/getting-to-zero-resources/hiv-report-2017/ (Accessed May 22, 2025) Global Fund. About the Global Fund. 2024. Available from: https://www.theglobalfund.org/en/about-the-global-fund/ (Accessed May 19, 2025) Gulick RM, Lalezari J, Goodrich J et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 2008;359:1429–41. Available from: https://doi.org/10.1056/NEJMoa0803152 Gulick RM, Mellors JW, Havlir D et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734–9. Available from: https://doi.org/10.1056/nejm199709113371102 Haubrich R, Berger D, Chiliade P et al. Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients. AIDS 2007;21:F11–8. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b47 HIV Prevention Trials Network. HPTN 052. 2023. Available from: https://www.hptn.org/research/studies/hptn052 (Accessed May 19, 2025) HIV.gov. HIV and AIDS timeline. 2024. Available from: https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline/ (Accessed May 19, 2025) HIVinfo.NIH.gov. FDA approval of HIV medicines. 2024. Available from: https://hivinfo.nih.gov/understanding-hiv/infographics/fda-approval-hiv-medicines (Accessed May 19, 2025) i-base. Cross-resistance by drug class. 2025. Available from: https://i-base.info/guides/changing/cross-resistance (Accessed May 19, 2025) Iyidogan P, Anderson KS. Current perspectives on HIV-1 antiretroviral drug resistance. Viruses 2014;6:4095–139. Available from: https://doi.org/10.3390/v6104095 Lalezari JP, Henry K, O'Hearn M et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 2003;348:2175–85. Available from: https://doi.org/10.1056/NEJMoa035026 Landovitz RJ, Donnell D, Clement ME et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med 2021;385:595–608. Available from: https://doi.org/10.1056/NEJMoa2101016 Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989;243:1731–4. Available from: https://doi.org/10.1126/science.2467383 Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr 2007;44:179–87. Available from: https://doi.org/10.1097/01.qai.0000247229.68246.c5 Lucas C. The San Francisco model and the nurses of Ward 5B. Lancet HIV 2019;6:E819. Available from: https://doi.org/10.1016/S2352-3018(19)30267-X Madruga JV, Cahn P, Grinsztejn B et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007;370:29–38. Available from: https://doi.org/10.1016/s0140-6736(07)61047-2 Marcelin AG. Resistance to nucleoside reverse transcriptase inhibitors. In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2241/ Margolis AM, Heverling H, Pham PA et al. A review of the toxicity of HIV medications. J Med Toxicol 2014;10:26–39. Available from: https://doi.org/10.1007/s13181-013-0325-8 Moore RD, Creagh-Kirk T, Keruly J et al. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group. Arch Intern Med 1991;151:981–6. Available from: https://doi.org/10.1001/archinte.1991.00400050123023 National Institute of Allergy and Infectious Diseases. HIV Undetectable = Untransmittable (U = U), or treatment as prevention. 2019. Available from: https://www.niaid.nih.gov/diseases-conditions/treatment-prevention (Accessed May 19, 2025) Nelson MR, Katlama C, Montaner JS et al. The safety of […] for the treatment of HIV infection in adults: the first 4 years. AIDS 2007;21:1273–81. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b33 New York State Department of Health. Pre-exposure prophylaxis (PrEP) to prevent HIV infection: question and answers. 2012. Available from: https://www.health.ny.gov/publications/0265/ (Accessed May 22, 2025) Overton ET, Richmond G, Rizzardini G et al. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with human immunodeficiency virus 1 type 1 infection: 152-week results from ATLAS-2M, a randomized, open-label, phase 3b, noninferiority study. Clin Infect Dis 2023;76:1646–54. Available from: https://doi.org/10.1093/cid/ciad020 Pollak EB, Parmar M. Indinavir. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554396/ (Accessed May 19, 2025) Richman DD, Fischl MA, Grieco MH et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192–7. Available from: https://doi.org/10.1056/nejm198707233170402 Schmit JC, Ruiz L, Clotet B et al. Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS 1996;10:995–9. Available from: https://doi.org/10.1097/00002030-199610090-00010 Siliciano JD, Kajdas J, Finzi D et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003;9:727–8. Available from: https://doi.org/10.1038/nm880 Steigbigel RT, Cooper DA, Kumar PN et al. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med 2008;359:339–54. Available from: https://doi.org/10.1056/NEJMoa0708975 TIME. Man of the year. 1996. Available from: https://time.com/vault/issue/1996-12-30/page/1/ (Accessed May 19, 2025) U.S. President's Emergency Plan for AIDS Relief (PEPFAR). About us. 2025. Available from: https://www.state.gov/about-us-pepfar/ (Accessed May 19, 2025)

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In today's rapidly evolving landscape, we witness significant strides shaping the future of drug development, patient care, and global market dynamics.Merck & Co. has made a notable advancement in cholesterol management with a PCSK9-targeted pill. This pill has achieved reductions in low-density lipoprotein cholesterol (LDL-C) comparable to existing injectable therapies. Such innovation represents a significant step forward by potentially offering a more convenient oral alternative for patients. The development underscores the industry's ongoing efforts to enhance patient compliance and therapeutic outcomes through novel drug delivery mechanisms.In a strategic corporate move, Pfizer has successfully acquired Metsera, an obesity biotech company, for a substantial $10 billion. This acquisition, which followed an intense bidding war with Novo Nordisk, exemplifies Pfizer's aggressive expansion in the obesity treatment market—a growing global health challenge. The strategic buyout positions Pfizer to leverage Metsera's expertise, potentially accelerating the development and commercialization of innovative obesity treatments.Meanwhile, Novo Nordisk is enhancing its presence in India by partnering with Emcure Pharmaceuticals to expand access to Wegovy, its weight-loss treatment. This collaboration is particularly significant given India's escalating obesity rates and highlights the importance of regional partnerships in enhancing drug accessibility and addressing public health issues.Regulatory developments continue to influence industry dynamics as well. The FDA has postponed its decision on expanding Rhythm Pharmaceuticals' Imcivree for additional indications. These regulatory delays highlight the complexities and unpredictabilities inherent in drug approval processes, underscoring the need for companies to strategically navigate these challenges.Regeneron and AstraZeneca have reported clinical trial successes with their respective anti-inflammatory drugs, Dupixent and Fasenra. These positive outcomes were showcased at the American College of Allergy, Asthma, and Immunology's annual meeting, bolstering the companies' aspirations for FDA approvals. Successful clinical outcomes not only pave the way for expanded therapeutic options but also demonstrate the industry's commitment to addressing complex inflammatory conditions.October has seen a surge in TV advertising spending, led by Johnson & Johnson's campaign for Tremfya. The campaign highlights the power of patient community engagement in bringing attention to conditions like inflammatory bowel disease (IBD), emphasizing how patient advocacy can reduce isolation among sufferers.In oncology, Cogent Biosciences is on track for an FDA submission following successful phase 3 trials of its cancer asset bezuclastinib. This development illustrates the critical role of rigorous clinical research in advancing oncology treatments and potentially improving patient outcomes.Turning our attention to technological frontiers within pharmaceutical R&D, Eli Lilly has been particularly active in cementing its commitment to artificial intelligence (AI) and gene therapy through several strategic collaborations. The company has entered into a $100 million-plus research agreement with Insilico Medicine to leverage AI for drug discovery. This partnership aims to expedite the identification of novel therapeutic targets and enhance drug development efficiency—a reflection of a broader industry trend towards integrating AI into pharmaceutical processes.Additionally, Lilly has made a notable move in gene therapy by acquiring rights from MeiraGTx for a retinal disease therapy that has shown Support the show

FULL SHOW: Tuesday, November 11th, 2025 Curious if we look as bad as we sound? Follow us @BrookeandJeffrey: Youtube Instagram TikTok BrookeandJeffrey.comSee omnystudio.com/listener for privacy information.See omnystudio.com/listener for privacy information.

“People know that asthma sucks. They don't know that sinus disease sucks. It really impacts people's quality of life. It impacts their function. It needs to be taken very seriously.” — Dr. Andrew ThambooChronic sinusitis doesn't just clog the nose—it can drag down quality of life, complicate asthma, and leave patients caught between specialists. Dr. Mariam Hanna talks with Dr. Andrew Thamboo, rhinologist at St. Paul's Sinus Centre in Vancouver and clinical associate professor at UBC, about how to identify, manage, and treat this stubborn condition. A leader in chronic sinus disease research, Dr. Thamboo explains how understanding inflammation, using the right investigations, and choosing the right therapies can make a real difference for patients who feel like nothing works.In this episode:How to distinguish chronic rhinosinusitis from acute sinusitis, and why type 2 inflammation mattersThe role of CT scans in diagnosis and when to order one before referralWhat nasal endoscopy patterns reveal about atopy and when allergy testing changes the treatment planWhy saline irrigations combined with topical steroids remain the baseline therapy, and why oral corticosteroids are falling out of favourWhen medical management has gone far enough and surgery becomes the next stepThe evolving place of biologics, cost considerations, and how biosimilars could shift the future of careWhy managing sinus disease seriously improves both airway and overall healthSinus disease may suck, but as Dr. Thamboo explains, understanding inflammation, anatomy, and timing can make all the difference for patients and physicians alike.Visit the Canadian Society of Allergy and Clinical ImmunologyFind an allergist using our helpful toolFind Dr. Hanna on X, previously Twitter, @PedsAllergyDoc or CSACI @CSACI_caThe Allergist is produced for CSACI by PodCraft Productions

Can anxiety about food safety quietly shape the way an entire family eats, lives, and loves? In this episode of Dr. Marianne-Land: An Eating Disorder Recovery Podcast, Dr. Marianne Miller, LMFT, talks with Tamara Hubbard, LCPC, founder of The Food Allergy Counselor and The Academy of Food Allergy Counseling. Together, they explore how food allergy anxiety can affect both children and parents, sometimes leading to ARFID-like eating patterns and significant emotional distress. Tamara shares her journey from being a parent of a child with a peanut allergy to becoming a national leader in the field of food allergy mental health. She discusses how chronic fear and misinformation can cause families to become trapped in cycles of hypervigilance and restriction. She and Dr. Marianne also examine how therapy can help families move toward flexibility, autonomy, and connection at the table. Listeners will hear how Acceptance and Commitment Therapy (ACT) and values-based approaches support parents in balancing safety with freedom, and how addressing anxiety can improve both emotional well-being and quality of life. Key Topics Covered The difference between food allergies and food intolerances and why accurate understanding matters How food allergy anxiety can spread through families and mimic ARFID symptoms The role of parental fear in shaping a child's own food relationship and daily life The risks of restriction-based medical advice, including some functional medicine practices How ACT and mindfulness tools can help parents tolerate fear and stay connected to their values Ways to calm the fight-or-flight response and reduce hypervigilance around food and safety Why collaboration between therapists and allergists creates stronger, safer support for families Who This Episode Is For This episode is for parents and caregivers who want to understand how food allergies, anxiety, and ARFID intersect in family life. It is also for therapists, dietitians, and healthcare providers who want to learn how to support families with evidence-based, trauma-informed, and values-driven care. Food Allergy Resources Mentioned Book: May Contain Anxiety: Managing the Overwhelm of Parenting Children With Food Allergies by Tamara Hubbard, LCPC (Johns Hopkins University Press, 2025) Website: The Food Allergy Counselor for educational articles, therapeutic resources, and directories of food allergy-informed therapists Organization: The Academy of Food Allergy Counseling for clinician training and professional community Article: Allergic Living Magazine Airline Allergy Travel Guide for details on how major airlines handle food allergy policies Advocacy Resource: No Nut Traveler by Leanne Mandelbaum, advocating for safer air travel for people with food allergies Therapeutic Framework: Acceptance and Commitment Therapy (ACT) for managing anxiety and values alignment Cultural Reference: We Can Do Hard Things by Glennon Doyle as a reminder of resilience and self-compassion Content Caution This episode includes discussions of allergic reactions, anaphylaxis, and eating challenges. Please take care while listening if these topics may feel activating or distressing. Learn More and Get ARFID and Selective Eating Support Visit ARFID and Selective Eating Course. This virtual program provides a compassionate, neurodivergent-affirming framework that helps families and clinicians create safety, flexibility, and understanding around food.

"Wrap up warm, or you'll catch a cold!" No doubt you heard that advice a lot as a child, and you may well still hear it as an adult. For a long time, scientists were skeptical about the idea that simply being exposed to the cold could make a person sick. After all, to get sick, you need to actually come into contact with a microbe, like a virus. And cold weather itself isn't a disease. But recent developments suggest there may actually be some truth to the idea. In December 2022, The Journal of Allergy and Clinical Immunology published a study by a team of American researchers, who had looked into how cold weather affected immunity in the nose. The researchers explained that our nasal mucous membranes, and in particular the extracellular vesicles, act as the first line of defense in our immune system against viral attacks. What do we know now that we didn't before? But is the cold the sole culprit? In under 3 minutes, we answer your questions! To listen to the last episodes, you can click here: ⁠How can I limit the effects of sugar on my health?⁠ ⁠What happens to your online life after you die?⁠ ⁠Why does cooking benefit our mental health?⁠ A podcast written and realised by Joseph Chance. First Broadcast: 24/9/2024 Learn more about your ad choices. Visit megaphone.fm/adchoices

When it comes to keeping kids with food allergies safe at school, school nurses are often the quiet heroes behind the scenes. From managing allergy action plans and emergency responses to training teachers and organizing care for hundreds of students, their role is essential, but often misunderstood. Kortney and Dr. Payel Gupta sit down with Elizabeth Elliott, a school nurse and President of the Maryland Association of School Health Nurses. Liz shares what really happens inside the health room and how school nurses coordinate care for students with food allergies and asthma. Plus, why communication between families and school staff is key to keeping kids safe. After this episode, you'll have a whole new appreciation for your school nurse and a better understanding of how to partner with them to make every school day safer for kids with allergies. What we cover about food allergy management at school: The school nurse's role: How nurses bridge communication between families, teachers, and doctors to keep children with food allergies safe and included during the school day. Coordinating care: How school nurses use action plans and 504s to ensure everyone, from teachers to cafeteria staff, knows how to keep kids safe. Training and emergency preparedness: How school nurses teach staff to recognize anaphylaxis, use epinephrine, and stay calm during an emergency. Field trips, cafeterias, and bus safety: What goes into planning safe experiences beyond the classroom, and why “no-food on the bus” rules really matter. Advocating for resources: How families can support their school nurses and advocate for better funding, staffing, and allergy awareness in schools. ___ Made in partnership with The Allergy & Asthma Network. Thanks to Genentech for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

An allergist says common health problems may be caused by food allergies. Dr. William Walsh is the author of "The Food Allergy Book." He explains the differences between two categories of food allergies, and how your body may crave the things that harm it the most. Everything from fruits to vitamins may lead to bad reactions, including sleepless night, headaches, stuffed noses & stomach problems. This 1999 interview is from WHO radio in Des Moines, Iowa. You can find all episodes on YouTube.

In episode 135 of Nonprofit Mission: Impact, Carol Hamilton talks with organizational design consultant Julian Chender about how nonprofits can move beyond simple restructuring to intentional organizational design that aligns strategy, structure, and process.  They discuss: how organizational design is not the same as restructuring how design choices impact effectiveness, collaboration, and long-term sustainability.  the pitfalls of designing around personalities,  the importance of strategic clarity when facing downsizing or merger decisions.  The conversation offers nonprofit leaders practical insights into building organizations that are resilient, adaptable, and positioned for impact.   Episode highlights: The Why Behind the Work -  [00:08:08]  Defining Organizational Design - [00:13:53]  Structure, Silos, and Collaboration - [00:14:41]  Common Mistakes in Nonprofit Design -  [00:18:23]  Balancing Human-Centered Values and Strategy -  [00:20:40]  Downsizing by Design - [00:24:36]  Participation and Ownership - [00:23:32]  Benchmarking vs. Mass Customization -  [00:30:01]  Strategic Plans Require Organizational Design - [00:37:40] Mergers and Strategic Alliances -  [00:41:21]  Examples of Successful Mergers -  [00:44:16]  The Key Question for Leaders - [00:47:57]    Guest Bio: Julian Chender is the founder of 11A Collaborative, an organization design firm focused on creating healthy society through healthy organizations. In his early years, Julian was an internal consultant at the National Institute of Allergy and Infectious Disease (NIAID) under Tony Fauci during the agency's response to the global Ebola and Zika crises. From there, he moved to external consulting, eventually joining Accenture's Operating Model & Organization Design practice shortly after its acquisition of Kates Kesler. Through 11A Collaborative, Julian has consulted to purpose-driven organizations across sectors. He is a Certified Organization Design Practitioner and an ICF-Certified Coach who holds a master's degree in Organization Development from American University and a B.A. in History from Swarthmore College. Important Links and Resources: Julian Chender 11A Collaborative Organization Design Forum Downsizing by Design: A Guide for Nonprofits Candid Social Impact Staff Retention survey Board Source Purpose Driven Leadership   Be in Touch: ✉️ Subscribe to Carol's newsletter at Grace Social Sector Consulting and receive the Common Mistakes Nonprofits Make In Strategic Planning And How To Avoid Them

For years, doctors warned parents to keep peanuts away from children until they turn three. But that advice backfired. Experts now say delayed exposure helped cause a peanut allergy surge in the U.S. Lessons for public health from peanut allergy advice.

Did you know that a dog allergy could be linked to unexplained infertility? This episode delves into fascinating allergy case studies and how component-resolved diagnostics can help uncover hidden connections. From wheat-dependent exercise-induced anaphylaxis in children to severe sesame reactions despite negative clinical history, learn what these interesting cases can teach us about the impact of allergen component sensitization and how innovative testing using components can broaden our understanding. This episode also explores the latest insights into wheat and sesame allergen components as well as how these tools can enhance your clinical decision-making, improve diagnostic accuracy, and optimize allergy management strategies. For episode resources and references, visit: https://www.thermofisher.com/phadia/us/en/resources/immunocast/allergy-case-studies-component-diagnostics-dog-sensitization-wheat-allergy-sesame-reactions.html?cid=0ct_3pc_05032024_9SGOV4

In this podcast accompanying the November issue of DTB (https://dtb.bmj.com/content/63/11) David Phizackerley (DTB Editor) is joined by Syba Sunny (DTB Clinical Editor). David and Syba discuss the editorial that argues that NHS budgets should not be used to ensure that pharmaceutical companies invest in the UK (https://dtb.bmj.com/content/63/11/162). They talk about a DTB Select article that summarises a systematic review and meta-analysis of trials that assessed patients with a reported penicillin or beta-lactam allergy who underwent direct oral penicillin challenge (https://dtb.bmj.com/content/63/11/163). They finish by discussing the main article that explores the intersection of medication errors, prescribing errors, harms resulting from the use of medicines and some legal consequences (https://dtb.bmj.com/content/63/11/168).   Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email dtb@bmj.com. Thank you for listening.

Will Truheight vitamins really make your kids grow?Where can I learn more about complementary medicine and nutrition?The balls of my feet are sore along with my toes. Is this a vitamin deficiency?

I recently had an ApoB test and am surprised that it isn't lower than it is.  Can you explain?I have an ascending thoracic aortic aneurysm.  How can I keep it from enlarging?Why are you against whole-body scans? Aren't they helpful?Can I take magnesium L-threonate while also taking magnesium glycinate?

Mucus plugging is a challenge in asthma care. It's thick, sticky mucus that blocks the airways and doesn't respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control. In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.” What we cover in our episode about dupilumab and mucus plugging Why mucus plugging matters in asthma: Discover how thick, sticky mucus can block airways, make it harder to breathe, and why standard inhalers and steroids don't clear these plugs. How dupilumab may help: Learn how this biologic blocks IL-4 and IL-13, two key drivers of type 2 inflammation that increase mucus production and thickness. Inside the VESTIGE study: Hear how researchers measured mucus burden using CT scans and “mucus plug scores” to see if dupilumab could reduce plugging in moderate-to-severe asthma. What the results showed: Find out how dupilumab lowered mucus plug scores, reduced airway inflammation, and improved lung function (FEV₁), especially in people with high mucus burden. What this means for patients: Learn why identifying and treating mucus plugging may help improve breathing, reduce flare-ups, and make asthma easier to manage day to day.

As kids, we often rely on our families to help keep us safe from allergens. But what happens when you're an adult heading out to restaurants, clubs, or Halloween parties? Today we're joined by Food Allergy Content Creator, Influencer, and Sarah and Spices founder, Sarah Danna, who's here to share practical tips for staying safe while still having a fun, worry-free Halloween.Resources to keep you in the know:Allergy and Anaphylaxis Emergency PlansSarah and Spices WebsiteFollow @sarahandspices on Instagram, Tik Tok, Pinterest, and You TubeYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: DBV TechnologiesThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

You can send and text and we love them.. but apparently we cant respond. Sorry!!A daily dose of good news in two minutes time... give or takeSupport the showJoin us on Facebook https://www.facebook.com/groups/awesomenewsdailyor email me at awesomenewsdaily@gmail.com

For decades, peanut allergies were on the rise in the US. But a study released on October 20 found that peanut allergies in babies and young children are now decreasing. This drop correlates with a change in guidance from the National Institute of Allergy and Infectious Diseases. In 2017, the agency started recommending exposing children to peanuts “early and often.” Since that recommendation, the prevalence of peanut allergies has dropped significantly.Sharon Chinthrajah, a physician specializing in allergies and immunology, churns through the findings with Host Flora Lichtman.  Guest: Dr. Sharon Chinthrajah is a physician specializing in allergy and immunology at the Sean N. Parker Center at Stanford University.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Want to heal your child's eczema without steroids and save $200 this week? Click here to get started → EczemaKids.com Use code EPISODE200 to get $200 off the Eczema Elimination Method.... the COMPLETE eczema-reversal system that actually works. This offer is good for one week only and ends Tuesday, November 4th, 2025. If your child's ever had an allergy test hoping for answers, only to walk out more confused or flaring, this episode is for you. As we celebrate 200 episodes (and my birthday week!), I'm breaking down what allergy tests actually measure, why kids with eczema often react badly, and how to tell the difference between true, serious IgE allergies and immune overload. We'll talk about why scratch tests and immunotherapy often do more harm than good for eczema families, what to do if your child already flared after testing, and how to start healing their skin and gut from the inside out.

Even the most experienced patients and caregivers can sometimes become a little too comfortable when it comes to managing epinephrine. Over time, it's easy to overlook key details or forget important steps. To help everyone stay sharp and fully prepared, renowned allergist, Dr. Michael Pistiner, joins us to talk all things epinephrine. Think of this conversation as both a refresher and a quick self-check to be sure you're up-to-date and ready when it matters most. Resources to keep you in the know:Allergy and Anaphylaxis Emergency PlansFAACT's Epinephrine Options PosterFAACT's Anaphylaxis ResourcesAllergy HomeYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: Aquestive TherapeuticsThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

ICE Video: https://www.youtube.com/watch?v=3yOqdhEEWng&t=577sTwitter: https://twitter.com/AntiWokePodcastYoutube: https://www.youtube.com/@antiwokepodcast8381/featuredTik Tok: https://www.tiktok.com/@anti_woke_podcast

Thousands of children may be avoiding peanut allergies thanks to research indicating that early exposure to—rather than avoidance of—the legume is key. Now there's reason to believe this is true for tons of allergens – and that the great “pandemic” of kid food allergies never needed to happen. Guest:  Dr. David Hill, attending physician with the Division of Allergy and Immunology at Children's Hospital of Philadelphia, and The Hill Lab. Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen. Podcast production by Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme, and Rob Gunther. Learn more about your ad choices. Visit megaphone.fm/adchoices

Thousands of children may be avoiding peanut allergies thanks to research indicating that early exposure to—rather than avoidance of—the legume is key. Now there's reason to believe this is true for tons of allergens – and that the great “pandemic” of kid food allergies never needed to happen. Guest:  Dr. David Hill, attending physician with the Division of Allergy and Immunology at Children's Hospital of Philadelphia, and The Hill Lab. Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen. Podcast production by Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme, and Rob Gunther. Learn more about your ad choices. Visit megaphone.fm/adchoices

Thousands of children may be avoiding peanut allergies thanks to research indicating that early exposure to—rather than avoidance of—the legume is key. Now there's reason to believe this is true for tons of allergens – and that the great “pandemic” of kid food allergies never needed to happen. Guest:  Dr. David Hill, attending physician with the Division of Allergy and Immunology at Children's Hospital of Philadelphia, and The Hill Lab. Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen. Podcast production by Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme, and Rob Gunther. Learn more about your ad choices. Visit megaphone.fm/adchoices

Living with constant congestion, facial pressure, or a loss of smell can make daily life exhausting. For many people, these symptoms are more than just allergies or a lingering cold. They may be signs of chronic rhinosinusitis with nasal polyps (CRSwNP). Dr. Rohit Katial joins Kortney and Dr. G to unpack what CRSwNP really is, how it develops, and why type 2 inflammation plays such a key role. Together, they explain what's happening inside the sinuses, what symptoms to look for, and when it's time to see a specialist. What we cover about CRSwNP: What CRSwNP means: Chronic rhinosinusitis with nasal polyps is long-term inflammation of the nose and sinuses that lasts 12 weeks or more. What nasal polyps are: Soft, fluid-filled sacs (often “grape” or “pea” sized) that block airflow and lead to congestion and smell loss. Why it happens: Type 2 inflammation drives CRSwNP. Immune messengers like IL-4, IL-5, and IL-13 cause swelling and fluid buildup in the nasal lining. Who it affects: CRSwNP often overlaps with asthma, allergies, or aspirin sensitivity (AERD or Samter's Triad), making symptoms worse. When to seek help: If congestion, pressure, or loss of smell lasts more than 12 weeks, see an allergist or an ENT specialist. Early care can prevent sinus damage and improve breathing and quality of life. More episodes to support CRSwNP Ep. 101: What is Type 2 Inflammation? Ep. 102: Comorbidities of Type 2 Inflammation -  Connecting the Dots Between Multiple Allergic Conditions Ep. 109: Tezepelumab & Nasal Polyps - Inside the WAYPOINT Phase III Trial ___ Made in partnership with The Allergy & Asthma Network. Thanks to AstraZeneca for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Send us a textWelcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recent trial examining whether amiloride is noninferior to spironolactone in reducing systolic blood pressure in patients with resistant hypertension. Here we go!Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial (0:00 – 8:10).Run-in studies:Application and impact of run-in studiesApplication and Impact of Run-In Studies for the Evaluation of Statin Efficacy and SafetyThe Good Stuff (8:11 - 9:14):Trial Files: https://trialfiles.substack.com/Heme Onc Trial Files: https://hemeonctrialfiles.substack.com/Allergy & Immunology Trial Files: https://allergyimmtrialfiles.substack.com/Critical Care Trial Files: https://criticalcaretrialfiles.substack.com/Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Anaphylaxis can happen to anyone, at any time — but when it comes to infants and toddlers, the signs, symptoms, and response can feel especially overwhelming. Do reactions look the same as in older children or adults? What about emergency steps and epinephrine dosing? To bring clarity and confidence to caregivers and the food allergy community, we're joined today by renowned allergist, Dr. Michael Pistiner, who will help clear up common questions, confusion, and fears around managing anaphylaxis in our youngest patients. Resources to keep you in the know:Allergy and Anaphylaxis Emergency PlansFAACT's Anaphylaxis ResourcesFAACT's Epinephrine Options Poster Allergy HomeYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: KaleoThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

Fluent Fiction - Catalan: Chocolate, Laughter, and An Unexpected Allergy Adventure Find the full episode transcript, vocabulary words, and more:fluentfiction.com/ca/episode/2025-10-22-07-38-19-ca Story Transcript:Ca: Martí mirava la façana del Museu de la Xocolata, el cor bategant fort.En: Martí looked at the facade of the Museu de la Xocolata, his heart pounding.Ca: Les fulles de la tardor ballaven al seu voltant mentre esperava Laia i Oriol.En: The autumn leaves danced around him as he waited for Laia and Oriol.Ca: Era el 31 d'octubre, i l'aire era fresc i ple de l'aroma dolça de castanyes i panellets.En: It was October 31st, and the air was fresh and filled with the sweet aroma of chestnuts and panellets.Ca: Laia va arribar amb un somriure radiant.En: Laia arrived with a radiant smile.Ca: Els seus ulls brillaven d'emoció pel passeig.En: Her eyes sparkled with excitement for the outing.Ca: Martí sabia que Laia adorava la xocolata, i això era la seva oportunitat per impressionar-la.En: Martí knew that Laia adored chocolate, and this was his chance to impress her.Ca: Oriol es va unir a ells amb el seu típic somriure entremaliat.En: Oriol joined them with his typical mischievous grin.Ca: Van entrar junts al museu, on els va rebre una atmosfera càlida i carregada del ric aroma de cacau.En: They entered the museum together, where they were greeted by a warm atmosphere laden with the rich aroma of cocoa.Ca: Escultures de xocolata es mostraven amb elegància, i Martí volia aprofitar-ho tot per semblar un expert davant Laia.En: Chocolate sculptures were elegantly displayed, and Martí wanted to take full advantage to seem like an expert in front of Laia.Ca: "Sabies que la xocolata blanca en realitat no conté cacau?En: "Did you know that white chocolate actually doesn't contain cocoa?"Ca: ", va començar a dir, amb Oriol fent una mueca divertida darrere seu.En: he began saying, with Oriol making a funny face behind him.Ca: Van començar el tast de xocolata.En: They began the chocolate tasting.Ca: Martí va provar diverses varietats: de Madagascar, de Veneçuela, fins i tot una de Papua Nova Guinea.En: Martí tried several varieties: from Madagascar, Venezuela, even one from Papua New Guinea.Ca: La Laia somreia i assentia amb entusiasme, i Martí es va sentir com un heroi.En: Laia smiled and nodded enthusiastically, and Martí felt like a hero.Ca: Però una de les xocolates tenia un sabor estrany, i Martí va començar a sentir una lleugera picor al coll.En: But one of the chocolates had a strange taste, and Martí started to feel a slight itch in his throat.Ca: No va voler preocupar a Laia, així que va somriure i va fer veure que tot anava bé.En: Not wanting to worry Laia, he smiled and pretended that everything was fine.Ca: Oriol, sempre atent, va notar que Martí començava a posar-se vermell.En: Oriol, always attentive, noticed that Martí was starting to turn red.Ca: "Estàs bé, Martí?En: "Are you okay, Martí?Ca: Et veig una mica inflat", va bromejar, encara que amb una mica d'inquietud.En: You look a bit swollen," he joked, although with some concern.Ca: Martí va sentir que la picor es convertia en una cosa més forta.En: Martí felt the itch turning into something stronger.Ca: "Tot bé", va insistir, cada vegada més incòmode.En: "All good," he insisted, increasingly uncomfortable.Ca: La Laia es va adonar del canvi en Martí i va preguntar, preocupada, "Estàs segur que tot està bé?En: Laia noticed the change in Martí and asked, worried, "Are you sure everything is okay?"Ca: " En aquell moment, Martí va esternudar tan fort que gairebé va fer caure una figura de xocolata.En: At that moment, Martí sneezed so loudly that he almost knocked over a chocolate figure.Ca: La situació va ser tan còmica que fins i tot ell va haver de riure, tot i la picor.En: The situation was so comical that he even had to laugh, despite the itch.Ca: Oriol va córrer a la farmàcia del carrer quan Martí va admetre que necessitava antihistamínics.En: Oriol ran to the pharmacy down the street when Martí admitted he needed antihistamines.Ca: La Laia el va acompanyar fora, rient pels esternuts sorollosos que Martí no podia contenir.En: Laia accompanied him outside, laughing at the noisy sneezes Martí couldn't contain.Ca: Finalment, un cop Martí va estar millor, la Laia el va mirar amb dolcesa.En: Finally, once Martí was feeling better, Laia looked at him sweetly.Ca: "Martí, no calia que fessis tot això per mi.En: "Martí, you didn't need to do all this for me.Ca: Em quedo amb els moments reals, no amb la perfecció.En: I cherish real moments, not perfection."Ca: " Martí es va adonar que ser autèntic era millor que impressionar amb façanes.En: Martí realized that being authentic was better than impressing with facades.Ca: Amb l'aire revitalitzat i sense els resta d'al·lèrgia, van decidir anar a veure les castanyeres a la plaça.En: With revitalized air and free of allergy remnants, they decided to visit the chestnut roasters in the square.Ca: Aquesta vegada, tots tres van riure junts, planejant properes trobades sense xocolata però plenes de rialles i autenticitat.En: This time, all three laughed together, planning future meetups without chocolate but filled with laughter and authenticity. Vocabulary Words:the facade: la façanathe museum: el museuthe chestnuts: les castanyesthe aroma: l'aromaradiant: radiantto sparkle: brillarthe mischief: l'entremaliatthe sculpture: l'esculturathe itch: la picorthe throat: el collthe concern: la inquietudto sneeze: esternudarthe pharmacy: la farmàciathe antihistamines: els antihistamínicsto cherish: valorarrevitalized: revitalitzatthe remnants: les restesto plan: planificarto pretend: fer veurethe atmosphere: l'atmosferathe aroma: l'aromathe outing: el passeigthe excitement: l'emocióthe opportunity: l'oportunitatto display: mostrarthe variety: la varietatto accompany: acompanyarthe authenticity: l'autenticitatthe hero: l'heroielegant: elegant

Research from the last decade of food allergies, shows that updated guidance had made a real impact on the number of people with allergies. Read more about the research here  ★ Support this podcast on Patreon ★

In this episode of SHE MD Podcast, Dr. Thaïs Aliabadi and Mary Alice Haney sit down with Dr. Tania Elliott to discuss allergies, immune health, and how hormonal changes impact symptoms. They explore practical strategies to reduce allergy triggers at home, boost immune health naturally, and adopt a personalized approach to allergy care. Dr. Elliott shares insights on seasonal allergies, food allergies, and hidden allergens in daily life, while providing actionable guidance for women navigating hormonal shifts during pregnancy, menopause, or with birth control. Listen to gain evidence-based tips to improve overall health, enhance quality of life, and take control of their wellness journey. Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD Podcast and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.Sponsors:Saje: Visit Saje.com to purchase plant powered products to remedy your needs. Use Code ‘SHEMD' for 20% off sitewide and free shippingOpill: Opill is birth control in your control, and you can use code SHEMD for twenty five percent off your first month of Opill at Opill.com.iRestore: For a limited time, get a HUGE discount on the iRESTORE Elite + Illumina Face Mask Bundle with code SHEMD at iRestore.comMerit: It's time to simplify your morning (Alt: Ready to simplify your routine?). Head to meritbeauty.com and get their Signature Makeup Bag free with your first order.Peloton: Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.comGetJoy: As a listener of SheMD, you'll get 50% off your first subscription order of Get Joy's Freeze Dried Raw Dog Food plus two exclusive gifts: a free scoop and a 4oz bag of treats. Shop getjoyfood.com/shemd to support your dog's gut health and overall wellnessProlon: For a limited time, you can be first in line to experience the new Next Gen at special savings. Prolon is offering SHE MD listeners 15% off sitewide plus a $40 bonus gift when you subscribe to their 5-Day Program!Cymbiotika: Go to Cymbiotika.com/Shemd for 20% off plus free shippingWhat You'll LearnUnderstanding how seasonal allergies, food allergies, and intolerances differHow hormonal changes impact allergy symptoms in womenStrategies to reduce allergy triggers at home and boost immune health naturallyWhen to use at-home allergy tests safely versus consulting a professionalKey Timestamps(02:42) Dr. Tania Elliott's Introduction (05:23) Dr. Elliott's journey in allergy and immunology(08:45) Common myths about allergies and immune health(13:10) Actionable tips: reducing triggers, hormonal considerations, lifestyle adjustments(22:24) Understanding seasonal vs. food allergies and intolerances(28:05) Hormonal shifts affecting immune system and allergies in women(35:58) Microplastics and toxins(49:29) Top 3 lifestyle changes to reduce allergens and improve healthKey Takeaways Seasonal allergies, food allergies, and intolerances affect women differently, especially during hormonal changesHidden allergens in everyday life can trigger reactions without noticeLifestyle factors like sleep, stress, and gut health influence immune resiliencePersonalized allergy care is more effective than one-size-fits-all approachesAt-home allergy tests can be helpful but professional guidance is essential for accurate diagnosisGuest BioDr. Tania Elliott is a dual board-certified physician specializing in Internal Medicine and Allergy/Immunology. She serves as a Clinical Instructor at NYU Langone Health and is a spokesperson for the American College of Allergy, Asthma, and Immunology. Dr. Elliott empowers people to take control of their health through actionable advice and personalized care. She is also the founder of Modern Medical, a consulting firm providing strategic support across healthcare sectors.Links:

Millions of people around the world were impacted by a major internet outage today, but an expert says it could have been much worse. Senators are returning to Capitol Hill today, with no compromise in sight to end the shutdown. President Donald Trump says tariffs are coming for Colombia. The FBI is investigating a “suspicious” hunting stand near Florida's Air Force One landing zone. Plus, some good news on preventing peanut allergies. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Navigating food allergies is tough enough, but adding family dynamics to the mix can make things even more complicated. When loved ones don't understand you or your child's allergies or dismiss the rules meant to keep them safe, it can lead to conflict, hurt feelings, and stress for everyone involved. Kortney and Dr. Payel Gupta sit down with psychologist Dr. Amanda Whitehouse to talk about how families can find common ground when emotions run high. Together, they unpack what it means to stay regulated in difficult conversations, how to set healthy boundaries with family members, and why understanding different coping styles can help prevent conflict before it starts. What we cover about communication and boundary-setting for food allergy families: Coping styles and conflict: Learn how different stress responses, such as “fight” versus “flight,” shape how partners, parents, and relatives react to food allergy challenges. Staying calm and regulated: Understand how your body reacts to stress and how recognizing those signals can help you stay grounded during tough conversations. Setting and holding boundaries: Get practical tips for explaining what feels safe, keeping communication clear, and responding calmly when others push back. Working together as a team: Whether it's with your partner, kids, or extended family, learn how to support each other and stay united when emotions rise. Bridging family differences: Explore ways to include children and siblings in allergy safety, and approach older relatives with patience and compassion when views or communication styles differ. ___ Made in partnership with The Allergy & Asthma Network. Thanks to Genentech for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In this episode, host Dr. Douglas Reh speaks with Dr. Masayoshi Takashima. They discuss the recently published Original Article: “3-Year Outcomes of Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve in Patients With Chronic Rhinitis.” The full manuscript is available as open access in the International Forum of Allergy and Rhinology. Listen and subscribe for […]

Episode 38 - Countdown to Chicago: What's Ahead at the CPNP Nutrition SymposiumIn this episode of Nutrition Pearls: the Podcast, host Nikki Misner speaks with Dr. Brock Williams and Tamara Sims Dorway about the upcoming CPNP Nutrition Symposium at the annual NASPGHAN meeting on November 6-8th in Chicago, Illinois. Brock Williams is a Registered Dietitian and Postdoctoral Research Fellow at the University of British Columbia (Vancouver, Canada). Over the past 10 years, he has worked as both a clinical and research dietitian at the Hospital for Sick Children (SickKids; Toronto), and at BC Children's Hospital (Vancouver) in areas such as Translational Medicine, Gastroenterology, and Allergy. His major clinical and research interests lie in micronutrients and childhood feeding (human milk feeding, complementary feeding and the prevention and treatment of food allergy). Brock currently serves as President-elect of CPNP. Tamara Sims Dorway is an experienced Registered Dietitian who is a board-certified specialist in pediatric nutrition. She is an integral part of the multidisciplinary team at the Center for Digestive Health and Nutrition at Arnold Palmer Hospital, where she provides comprehensive nutritional care for children and families facing a range of GI challenges. She has previously served on the CPNP planning committee for NASPGHAN and was the communications co-chair for POWER (Pediatric Obesity Weight Evaluation Registry).  She enjoys volunteering in her community and spending time with her family. She is the current CPNP Program ChairNutrition Pearls is supported by an educational grant from Mead Johnson Nutrition.Resources:NASPGHAN 2025 Annual Meeting NASPGHAN 2025 App Produced by: Corey IrwinNASPGHAN - Council for Pediatric Nutrition Professionalscpnp@naspghan.org

We end the futile struggle, embrace the toxins, and become one with our mould brethren.The full episode is available to Patreon subscribers (2 hours, 38 minutes).Join us at: https://www.patreon.com/DecodingTheGurusSupplementary Material 3800:00 Intro02:54 Boomer Matt reacts to Twitter videos07:31 Shellenberger and Tucker discuss the 9/11 Files12:42 Eric's Google Ngram Investigations17:08 Vindication on the Elephant Graveyard22:00 Eric's ARC lecture goes viral25:24 Andrew Huberman is NOT a phrenologist...29:06 Eric Weinstein vs. Piers Morgan33:44 Everyone knows Eric is a serious thinker46:09 Peterson is taken out of the Gurusphere by Demons and Toxic Mould52:09 Gurus and Bespoke Alternative Health57:00 Social Contagion Hypocrisy01:02:55 Toxic Mould Symbiosis?01:04:46 Pewdiepie, Diogenes, and the Seeker Mindset01:16:14 The Wisdom of the Ancients01:21:01 The Meaning Crisis and Christian Pivots01:22:29 Konstantin Kisin's surprising Christian pivot01:25:17 The best person Konstantin ever met (not Francis)01:30:22 The Fifth Column Agrees with Megyn Kelly 88% of the time01:33:07 Megyn Kelly explains how the Democrats crossed the line and must pay01:41:35 Intellectual Clerics for MAGA01:43:16 Slightly Adversarial libertarians for hire01:47:00 Drew Pavlou and Fluid Populism01:50:17 Two Varieties of Online Derangement: Noah Smith's Hot Takes01:53:57 Need for Attention = Desire for Virality01:57:23 Status Seeking Networkers vs Paul Bloom02:01:27 Reflecting on the Al Murray Interview02:02:22 The struggle of podcasters02:04:52 Paul Bloom: The best person in the world?02:06:00 Mike Israetel's Thesis Controversy02:10:30 What does a PhD mean?02:16:55 David Deutsch visits Curt Jaimungal02:22:32 The Dangers of Doubling Down: Pirate Software02:23:32 Hasan Piker and Shock Collar-gate02:27:15 Matt's Take on Shock Collars02:33:51 Dystopia Update: Putin wants Trump to win the Nobel Prize02:37:11 OutroSourcesShellenberger and Tucker discuss the CIA's role in 9/11Grok pressing Eric to get specificThe Elephant GraveyardViral post about Eric's ARC speech on scienceHuberman's phrenology endorsementJordan Peterson's Health Update from MikhailaChris Williamson: It's time to talk about my health.Chang, C., & Gershwin, M. E. (2019). The myth of mycotoxins and mold injury. Clinical Reviews in Allergy & Immunology, 57(3), 449–455.Borchers, A. T., Chang, C., & Eric Gershwin, M. (2017). Mold and human health: A reality check. Clinical Reviews in Allergy & Immunology, 52(3), 305–322.

We are joined by Carina Venter, PhD — gut diversity expert, researcher, and registered dietitian—to unpack how gut health influences people living with food allergies. She'll also share insights on using everyday foods as a powerful tool to help prevent food allergies in infants.Resources to keep you in the know:FAACT's Latest Research of Food Allergy PreventionFAACT's What to Do to Protect Against Food AllergiesLet's Grow Happy Feeding Allergen GuideYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: GenentechThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

Fluid overload is a common problem in critically ill patients. In this episode, Dr. Sergio Zanotti discuss recognizing and managing fluid overload in the ICU with guest Dr. Michael J. Connor, Jr., a practicing intensivist and nephrologist. Dr. Connor is a Professor and Senior Physician of Critical Care Medicine & Nephrology at the Divisions of Pulmonary, Allergy, Critical Care, and Sleep Medicine and Renal Medicine at Emory University School of Medicine. Additionally, he serves as the director of critical care nephrology at the Emory Critical Care Center at Grady Memorial Hospital. Additional resources European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3- fluid removal at de-escalation phase. Intensive Care Med 2025: https://pubmed.ncbi.nlm.nih.gov/40828463/ Optimizing Fluid Therapy in the Critically Ill. International Fluid Academy website – 2025: https://www.fluidacademy.org/2025/01/17/optimising-fluid-therapy-in-the-critically-ill-introduction-to-7d/ Fluid overload in the ICU: evaluation and management. R. Claure-Del Granado and R. L. Mehta. BMC Nephrology 2016: https://pubmed.ncbi.nlm.nih.gov/27484681/ Books and music mentioned in this episode: Think Again: The Power of Knowing What You Don't Know. By Adam Grant: https://bit.ly/4gZvz9c RUSHMERE. By Mumford & Sons: https://bit.ly/473FzKc

Allergy woes, haircuts, and fall weather. Drawtober art prompts, dieting, and the gift of Hades II. A Cult of the Lamb trivia quiz. Cozy games (Peak, Thank Goodness You're Here), job-hunting, AI video tools like Sora, and family chats about politics, empathy, and nuance. Grumpiness, kindness, and knocking over Girl Scouts, all on this weeks Monday Show. Hosted on Acast. See acast.com/privacy for more information.

Benadryl's active ingredient, diphenhydramine, is now considered outdated and unsafe, with researchers urging that it be removed from over-the-counter use The drug causes strong sedation, impaired memory, and slower reaction times, with studies showing it affects driving performance more than alcohol Older adults face lingering grogginess for up to 18 hours, while children risk unpredictable reactions, including agitation, coma, or heart problems if overdosed Other countries have already restricted access, and medical authorities warn against its use in children, highlighting safer alternatives and lifestyle strategies Natural approaches like vitamin C, quercetin, whole foods, restorative sleep, and stress management help balance histamine and reduce allergy symptoms without dangerous side effects

These diseases - West Nile Virus, Lyme disease, and Rocky Mountain Spotted Fever - are named for the places where outbreaks happened. But they're also all things you get from being bitten by mosquitoes or ticks. Research: Balasubramanian, Chandana. “Rocky Mountain Spotted Fever (RMSF): The Deadly Tick-borne Disease That Inspired a Hit Movie.” Gideon. 9/1/2022. https://www.gideononline.com/blogs/rocky-mountain-spotted-fever/ Barbour AG, Benach JL2019.Discovery of the Lyme Disease Agent. mBio10:10.1128/mbio.02166-19.https://doi.org/10.1128/mbio.02166-19 Bay Area Lyme Foundation. “History of Lyme Disease.” https://www.bayarealyme.org/about-lyme/history-lyme-disease/ Caccone, Adalgisa. “Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes.” Yale School of Medicine. 8/28/2017. https://medicine.yale.edu/news-article/ancient-history-of-lyme-disease-in-north-america-revealed-with-bacterial-genomes/ Chowning, William M. “Studies in Pyroplasmosis Hominis.("Spotted Fever" or "Tick Fever" of the Rocky Mountains.).” The Journal of Infectious Diseases. 1/2/1904. https://archive.org/details/jstor-30071629/page/n29/mode/1up Elbaum-Garfinkle, Shana. “Close to home: a history of Yale and Lyme disease.” The Yale journal of biology and medicine vol. 84,2 (2011): 103-8. Farris, Debbie. “Lyme disease older than human race.” Oregon State University. 5/29/2014. https://science.oregonstate.edu/IMPACT/2014/05/lyme-disease-older-than-human-race Galef, Julia. “Iceman Was a Medical Mess.” Science. 2/29/2012. https://www.science.org/content/article/iceman-was-medical-mess Gould, Carolyn V. “Combating West Nile Virus Disease — Time to Revisit Vaccination.” New England Journal of Medicine. Vol. 388, No. 18. 4/29/2023. https://www.nejm.org/doi/full/10.1056/NEJMp2301816 Harmon, Jim. “Harmon’s Histories: Montana’s Early Tick Fever Research Drew Protests, Violence.” Missoula Current. 7/20/2020. https://missoulacurrent.com/ticks/ Hayes, Curtis G. “West Nile Virus: Uganda, 1937, to New York City, 1999.” From West Nile Virus: Detection, Surveillance, and Control. New York : New York Academy of Sciences. 2001. https://archive.org/details/westnilevirusdet0951unse/ Jannotta, Sepp. “Robert Cooley.” Montana State University. 10/12/2012. https://www.montana.edu/news/mountainsandminds/article.html?id=11471 Johnston, B L, and J M Conly. “West Nile virus - where did it come from and where might it go?.” The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 11,4 (2000): 175-8. doi:10.1155/2000/856598 Lloyd, Douglas S. “Circular Letter #12 -32.” 8/3/1976. https://portal.ct.gov/-/media/departments-and-agencies/dph/dph/infectious_diseases/lyme/1976circularletterpdf.pdf Mahajan, Vikram K. “Lyme Disease: An Overview.” Indian dermatology online journal vol. 14,5 594-604. 23 Feb. 2023, doi:10.4103/idoj.idoj_418_22 MedLine Plus. “West Nile virus infection.” https://medlineplus.gov/ency/article/007186.htm National Institute of Allergy and Infectious Disease. “History of Rocky Mountain Labs (RML).” 8/16/2023. https://www.niaid.nih.gov/about/rocky-mountain-history National Institute of Allergy and Infectious Disease. “Rocky Mountain Spotted Fever.” https://www.niaid.nih.gov/diseases-conditions/rocky-mountain-spotted-fever Rensberger, Boyce. “A New Type of Arthritis Found in Lyme.” New York Times. 7/18/1976. https://www.nytimes.com/1976/07/18/archives/a-new-type-of-arthritis-found-in-lyme-new-form-of-arthritis-is.html?login=smartlock&auth=login-smartlock Rucker, William Colby. “Rocky Mountain Spotted Fever.” Washington: Government Printing Office. 1912. https://archive.org/details/101688739.nlm.nih.gov/page/ Sejvar, James J. “West Nile virus: an historical overview.” Ochsner journal vol. 5,3 (2003): 6-10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3111838/ Smithburn, K.C. et al. “A Neurotropic Virus Isolated from the Blood of a Native of Uganda.” The American Journal of Tropical Medicine and Hygiene. Volume s1-20: Issue 4. 1940. Steere, Allen C et al. “The emergence of Lyme disease.” The Journal of clinical investigation vol. 113,8 (2004): 1093-101. doi:10.1172/JCI21681 Steere, Allen C. et al. “Historical Perspectives.” Zbl. Bakt. Hyg. A 263, 3-6 (1986 ). https://pdf.sciencedirectassets.com/281837/1-s2.0-S0176672486X80912/1-s2.0-S0176672486800931/main.pdf World Health Organization. “West Nile Virus.” 10/3/2017. https://www.who.int/news-room/fact-sheets/detail/west-nile-virus Xiao, Y., Beare, P.A., Best, S.M. et al. Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine. Sci Rep 13, 4687 (2023). https://doi.org/10.1038/s41598-023-31894-0 See omnystudio.com/listener for privacy information.